These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 24548663)

  • 1. Sleep duration, C-reactive protein and risk of incident coronary heart disease--results from the Framingham Offspring Study.
    Liu J; Yuen J; Kang S
    Nutr Metab Cardiovasc Dis; 2014 Jun; 24(6):600-5. PubMed ID: 24548663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-reactive protein and the 10-year incidence of coronary heart disease in older men and women: the cardiovascular health study.
    Cushman M; Arnold AM; Psaty BM; Manolio TA; Kuller LH; Burke GL; Polak JF; Tracy RP
    Circulation; 2005 Jul; 112(1):25-31. PubMed ID: 15983251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Higher level of systemic C-reactive protein is independently predictive of coronary heart disease in older community-dwelling adults: the three-city study.
    Straczek C; Ducimetiere P; Barberger-Gateau P; Helmer C; Ritchie K; Jouven X; Carcaillon L; Amouyel P; Tzourio C; Empana JP
    J Am Geriatr Soc; 2010 Jan; 58(1):129-35. PubMed ID: 20002508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study.
    Ballantyne CM; Hoogeveen RC; Bang H; Coresh J; Folsom AR; Heiss G; Sharrett AR
    Circulation; 2004 Feb; 109(7):837-42. PubMed ID: 14757686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-reactive protein modulates risk prediction based on the Framingham Score: implications for future risk assessment: results from a large cohort study in southern Germany.
    Koenig W; Löwel H; Baumert J; Meisinger C
    Circulation; 2004 Mar; 109(11):1349-53. PubMed ID: 15023871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative analysis of red cell distribution width and high sensitivity C-reactive protein for coronary heart disease mortality prediction in multi-ethnic population: findings from the 1999-2004 NHANES.
    Veeranna V; Zalawadiya SK; Panaich S; Patel KV; Afonso L
    Int J Cardiol; 2013 Oct; 168(6):5156-61. PubMed ID: 24016543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study on C-reactive protein and the risk factors of traditional coronary heart disease].
    Guo ZR; Hu XS; Chen FM; Wu M
    Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Nov; 28(11):1064-8. PubMed ID: 18396656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-reactive protein and interleukin-18 levels in relation to coronary heart disease: prospective cohort study from Busselton Western Australia.
    Hung J; Knuiman MW; Divitini ML; Langton PE; Chapman CL; Beilby JP
    Heart Lung Circ; 2008 Apr; 17(2):90-5. PubMed ID: 17851127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronary disease risk prediction algorithm warranting incorporation of C-reactive protein in Turkish adults, manifesting sex difference.
    Onat A; Can G; Hergenç G; Uğur M; Yüksel H
    Nutr Metab Cardiovasc Dis; 2012 Aug; 22(8):643-50. PubMed ID: 21315565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incident diabetes mellitus may explain the association between sleep duration and incident coronary heart disease.
    Svensson AK; Svensson T; Kitlinski M; Almgren P; Engström G; Nilsson PM; Melander O
    Diabetologia; 2018 Feb; 61(2):331-341. PubMed ID: 29103105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma concentration of C-reactive protein and the calculated Framingham Coronary Heart Disease Risk Score.
    Albert MA; Glynn RJ; Ridker PM
    Circulation; 2003 Jul; 108(2):161-5. PubMed ID: 12835213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mediation analysis of metabolic and inflammatory factors in the severe sleep apnea-coronary heart disease association.
    Lin J; Sheng B; Zhang X
    Postgrad Med J; 2023 Dec; 100(1179):28-35. PubMed ID: 37827536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-reactive protein, interleukin-6, and fibrinogen as predictors of coronary heart disease: the PRIME Study.
    Luc G; Bard JM; Juhan-Vague I; Ferrieres J; Evans A; Amouyel P; Arveiler D; Fruchart JC; Ducimetiere P;
    Arterioscler Thromb Vasc Biol; 2003 Jul; 23(7):1255-61. PubMed ID: 12775578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations between very low concentrations of low density lipoprotein cholesterol, high sensitivity C-reactive protein, and health outcomes in the Reasons for Geographical and Racial Differences in Stroke (REGARDS) study.
    Penson PE; Long DL; Howard G; Toth PP; Muntner P; Howard VJ; Safford MM; Jones SR; Martin SS; Mazidi M; Catapano AL; Banach M
    Eur Heart J; 2018 Oct; 39(40):3641-3653. PubMed ID: 30165636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High attributable risk of elevated C-reactive protein level to conventional coronary heart disease risk factors: the Third National Health and Nutrition Examination Survey.
    Miller M; Zhan M; Havas S
    Arch Intern Med; 2005 Oct; 165(18):2063-8. PubMed ID: 16216995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-reactive protein, bezafibrate, and recurrent coronary events in patients with chronic coronary heart disease.
    Haim M; Benderly M; Tanne D; Matas Z; Boyko V; Fisman EZ; Tenenbaum A; Zimmlichman R; Battler A; Goldbourt U; Behar S
    Am Heart J; 2007 Dec; 154(6):1095-101. PubMed ID: 18035081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of exercise testing in the prediction of coronary disease risk among asymptomatic persons as a function of the Framingham risk score.
    Balady GJ; Larson MG; Vasan RS; Leip EP; O'Donnell CJ; Levy D
    Circulation; 2004 Oct; 110(14):1920-5. PubMed ID: 15451778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased concentrations of C-reactive protein and IL-6 but not IL-18 are independently associated with incident coronary events in middle-aged men and women: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002.
    Koenig W; Khuseyinova N; Baumert J; Thorand B; Loewel H; Chambless L; Meisinger C; Schneider A; Martin S; Kolb H; Herder C
    Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2745-51. PubMed ID: 17008587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-reactive protein and prognosis in women and men with coronary artery disease after percutaneous coronary intervention.
    Ndrepepa G; Braun S; Cassese S; Fusaro M; King L; Kastrati A; Schmidt R
    Cardiovasc Revasc Med; 2013; 14(5):264-9. PubMed ID: 23969223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-reactive protein in adults with pulmonary arterial hypertension associated with congenital heart disease and its prognostic value.
    Scognamiglio G; Kempny A; Price LC; Alonso-Gonzalez R; Marino P; Swan L; D' Alto M; Hooper J; Gatzoulis MA; Dimopoulos K; Wort SJ
    Heart; 2014 Sep; 100(17):1335-41. PubMed ID: 24790070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.